Tsukuba, Japan

Emiko Kitagawa



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Emiko Kitagawa: Innovator in Toxic Substance Detection

Introduction

Emiko Kitagawa is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of toxic substance detection through innovative biological processes. With a total of 2 patents, his work has the potential to impact various industries focused on safety and environmental health.

Latest Patents

Emiko Kitagawa's latest patents include advanced processes for detecting toxic substances. One of his notable inventions involves biology-based processes that detect mRNA expressed in the presence of toxic substances using cells that contain yeast genes or homologous genes from other species. This method allows for the identification of toxic compounds effectively. Another patent focuses on transforming cells with a vector that includes a polynucleotide linked to a yeast gene promoter and a marker protein. This process enables the detection of toxic compounds in test samples by monitoring the expression of mRNA encoding the marker protein.

Career Highlights

Throughout his career, Emiko Kitagawa has worked with prominent companies such as Daiken Industries, Ltd. and Daikin Industries, Ltd. His experience in these organizations has contributed to his expertise in developing innovative solutions for detecting harmful substances.

Collaborations

Emiko has collaborated with talented individuals in his field, including Hitoshi Iwahashi and Yuko Momose. Their combined efforts have further advanced the research and development of effective detection methods.

Conclusion

Emiko Kitagawa's contributions to the detection of toxic substances through innovative biological processes highlight his role as a leading inventor in this critical area. His patents and collaborations reflect a commitment to enhancing safety and environmental health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…